
Phase II proof-of-concept study indicates efficacy signals at day 28 and day 84

Phase II proof-of-concept study indicates efficacy signals at day 28 and day 84



In a well-matched sample group, patients with higher levels of postoperative astigmatism reported a greater improvement in quality of life and a greater rate of willingness to have the procedure again if they received an Extended Depth of Focus IOL compared to patients receiving a low-add, multifocal IOL, despite similar postoperative clinical and patient reported performance.

Researchers conducted a 6-month study of patients implanted with the AcrySof IQ PanOptix presbyopia-correcting IOL to determine the binocular defocus curve of the lens. They concluded that these early results show good visual performance across the whole range of defocus. No unexpected adverse events were reported

When dealing with patients with retinal disease, macular disease, or a meaningful risk of retinal detachment, certain types of IOLs should be avoided due to potential complications.

Using the Descemet’s membrane endothelial keratoplasty (DMEK) procedure can produce better visual results and lower risk of rejection than using the previous methods (DLEK and DSAEK). The method has become easier to learn and use than in the past, and should be considered as the primary EK procedure for most routine cases of endothelial failure.

The most common complication associated with the explantation of foldable intraocular lenses (IOLs) is lens dislocation or decentration. While glare and visual aberrations are the most common reasons for explanting multifocal lenses.

The implementation of electronic health records has had great impact on the way ophthalmologists spend their time. There are concerns that this has created inefficiencies, and that physicians now spend more time documenting, and less time with their patients, which is the opposite of what was intended.